Table S1 - Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the U.S
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
Demographic and clinical characteristics of patients receiving caspofungin, voriconazole and older antifungal agents. Numbers are percents of patients unless indicated otherwise. (DOCX)
创建时间：
2014-01-10
